Showing results (11-20 of 175) with videos related to

Sort By:
Pageof 18
Gynecologic Oncology|August 1, 1996
Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group studyG Sutton, J A Blessing, J H Malfetano
American Journal of Clinical Oncology|June 1, 1990
Echinomycin (NSC 526417) in squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology GroupH B Muss, J A Blessing, J Malfetano
Gynecologic Oncology|December 6, 2000
Phase II trial of CI-958 in recurrent platinum-refractory ovarian carcinoma. A Gynecologic Oncology Group StudyM A Hoffman, J A Blessing, M Morgan
Gynecologic Oncology|February 28, 1998
Evaluation of cisplatin and cyclosporin A in recurrent platinum-resistant ovarian cancer: a phase II study of the gynecologic oncology groupA Manetta, J A Blessing, J A Hurteau
Gynecologic Oncology|July 1, 1996
Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group StudyP G Rose, J A Blessing, J Arseneau
Gynecologic Oncology|March 1, 1992
A phase II trial of didemnin B (NSC No. 325319) in advanced and recurrent cervical carcinoma: a Gynecologic Oncology Group studyA J Jacobs, J A Blessing, A Munoz
American Journal of Clinical Oncology|February 1, 1986
Cisplatin as second-line chemotherapy in the treatment of advanced or recurrent leiomyosarcoma of the uterus. A phase II trial of the Gynecologic Oncology GroupJ T Thigpen, J A Blessing, G D Wilbanks
Gynecologic Oncology|May 24, 2001
A phase II trial of CI-958 in recurrent platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group studyM A Hoffman, J A Blessing, E R Nuñez
Gynecologic Oncology|August 1, 1993
Salvage intraperitoneal therapy of ovarian cancer employing cisplatin and etoposide: a Gynecologic Oncology Group studyM Markman, J A Blessing, F Major, et al.
American Journal of Clinical Oncology|June 17, 1998
A phase II trial of amonafide in patients with mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group studyR Asbury, J A Blessing, E Podczaski, et al.
Pageof 18